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Neutralization of Budded Autographa californica NPV by a Monoclonal 
Antibody: Identification of the Target Antigen 
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AND PETER FAULKNER? 
*Department of Entwnwlogy and Parasitology, University of Cal@rnia, Berkeley, CalQbrnia, 94720, and 
tDepartment of Microbiology and Immunology, Queen’s University, Kingston, Ontario, KYLSN6 Canada 
Received October 5, 1983; accepted December 16, 1983 
A neutralizing monoclonal antibody of the budded phenotype of Autographa caZ@rnica 
nuclear polyhedrosis virus did not react with the occluded form of the virus as determined 
by neutralization, ELISA, and indirect immunoperoxidase staining. The antibody did 
react with the surface of infected cells in the prepolyhedra stage of cytopathic effect, the 
period of active virus budding. Immunoelectron microscopy indicated the antigen(s) reactive 
with the neutralizing antibody was present all around the viral envelope, but was more 
highly concentrated at the end with peplomers. Four proteins were immunoprecipitated 
from solubilized, radiolabeled budded virus preparations with the monoclonal antibody. 
The major protein had a molecular weight of approximately 64,000, while the other three 
were approximately 12’7,000, 59,000, and 49,000. All four proteins could be labeled with 
N-acetyl-D-[l-3HJglucosamine. This glycosylation reaction could be inhibited by tunica- 
mycin. 
INTRODUCTION 
It is now well recognized that Autogra- 
pha califmica nuclear polyhedrosis virus 
(AcNPV), the type species of subgroup A 
baculoviruses, generates two separate 
phenotypes during the course of infection 
(Faulkner, 1981). These two phenotypes 
appear to have specific roles in the persis- 
tence of the virus in nature. The occluded 
form (OV), which gains its envelope in the 
nucleus before being incorporated into the 
polyhedral protein matrix, is thought to 
be responsible for the transmission of in- 
fection from one larva to the next. The 
polyhedra, released into the environment 
by the liquification of infected, diseased 
insects, are ingested by susceptable larvae 
and are dissolved by the alkaline pH of the 
midgut juices. The occluded virions, 
thereby released into the gut lumen, are 
freed to infect the midgut cells. The second 
phenotype, the budded virus (BV), gains 
its envelope by budding through the plasma 
membrane of infected cells. This form is 
1 Author to whom requests for reprints should be 
addressed. 
thought to be responsible for transmitting 
infection from one tissue to another within 
an infected insect. 
Larvae-grown occluded virions can be 
artificially released from polyhedra in the 
laboratory by exposure to alkali. This lar- 
vae-occluded virus, alkali liberated 
(LOVAL) has been compared to BV and 
has been found to be different morpholog- 
ically, biologically, and biochemically 
(Volkman, 1983), even though the genomes 
of the two phenotypes have been shown to 
be the same by restriction endonuclease 
analysis (Smith and Summers, 1978). Ger- 
mane to this report are the observations 
that BV possesses polar peplomers while 
LOVAL does not (Adams et ak, 1977). Dif- 
ferences in infectivity have also been doc- 
umented; BV is much more highly infec- 
tious in the hemocoel than in the gut (1 
X 105-fold greater), while LOVAL is three 
times more highly infectious in the gut 
than in the hemocoel. In cell culture, BV 
is about 1.88 X lo3 times more infectious 
than LOVAL (Volkman and Summers, 
1977). A third observation pertinent to this 
report is that BV and LOVAL are neu- 
tralized by different populations of anti- 
0042-6822/34 $3.00 
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bodies (Volkman et ah, 1976). The avail- 
ability of a neutralizing monoclonal an- 
tibody of the BV phenotype of AcNPV 
(Hohmann and Faulkner, 1983) afforded 
the opportunity to further compare the 
LOVAL and BV phenotypes with regard 
to their reaction with this antibody, and 
to identify the BV antigen recognized by 
the antibody. Results of this investigation 
revealed that the antibody did not recog- 
nize the LOVAL phenotype at all, but re- 
acted with surface antigens on infected 
cells in the prepolyhedra stage of cyto- 
pathic effect (CPE) (Volkman and Sum- 
mers, 19’75), the period of active virus bud- 
ding (Volkman et ah, 1976). The BV anti- 
gen(s) recognized was a glycoprotein 
incorporated throughout the BV envelope, 
but was more concentrated at the end of 
the virus containing peplomers. Four gly- 
coproteins of molecular weights 127,000, 
64,000, 59,000, and 49,000 were identified 
by the immunoprecipitation of solubilized 
radiolabeled BV structural proteins with 
the neutralizing monoclonal antibody. The 
relationship of these proteins to one an- 
other has yet to be established. 
MATERIALS AND METHODS 
Cell Culture 
All studies were conducted with Spo- 
doptera f+ugiperda IPLB-SF-21 cells grown 
at 28” in BML-TC/lO medium (Gardiner 
and Stockdale, 1970) with 10% fetal calf 
serum. 
Virus 
The virus was the E2 variant of AcNPV 
(Smith and Summers, 1978). Budded virus 
used in ELISA was third passage virus 
from 48 hr culture medium of infected 
IPLB-SF-21 cells. This virus was purified 
by differential centrifugation and sucrose 
density gradients described by Volkman et 
al. (1976). LOVAL was obtained and pu- 
rified as described by Volkman (1983). 
Source of Antibodies 
The generation and preliminary char- 
acterization of the monoclonal antibody 
AcV, was described by Hohmann and 
Faulkner (1983). The lymphocyte hybrid- 
oma cells producing AcVi were maintained 
in Dulbecco’s modified Eagles medium 
(DMEM) with 20% fetal calf serum in a 
7% C02-93% air environment at 37”. Con- 
ditioned DMEM was the source of hybri- 
doma antibody. Antiserum to electropho- 
retically purified BV 64,000 molecular 
weight protein (BVP 64) was provided by 
Dr. James Maruniak, University of Florida, 
Gainsville, Fla. 
ELISA 
Indirect ELISA was performed essen- 
tially as described by Voller et al. (1979). 
Gilford cuvette strips were coated with pu- 
rified virus by incubating either BV or 
LOVAL at 5 pg/ml in 0.05 M sodium car- 
bonate (pH 9.6) overnight at 4”. The strips 
were washed three times by hand in 0.15 
M NaCl and 0.1% Tween 20 after this in- 
cubation and all others. DMEM alone or 
containing AcVl was diluted in indirect 
buffer (0.1 Mphosphate-buffered saline, pH 
7.4, 0.05% Tween 20, 2% polyvinylpyrroli- 
done-lo, and 0.5% bovine serum albumin) 
and incubated in wells containing virus for 
2 hr at 35” on a rotary shaker at 60 rpm. 
After washing, alkaline phosphatase-cou- 
pled goat anti-mouse IgG diluted in indi- 
rect buffer was added and incubated as in 
the previous step. Following another wash, 
the substrate p-nitrophenyl phosphate was 
added at 1 mg/ml in 10% diethanolamine, 
pH 9.8, and incubated for 1 hr at 35”. The 
optical density of the reaction product in 
each well was determined at 405 nm with 
a Gilford PR 50 EIA processor. 
Neutralization Experiments 
Neutralization experiments were per- 
formed by diluting 160 to 100 plaque form- 
ing units (PFU) of AcNPV BV or LOVAL 
1:2 with a known dilution of DMEM (alone 
or containing AcV1) and incubating 1 hr 
at 37”. The number of remaining infectious 
virions was determined by the immuno- 
peroxidase infectivity assay (Volkman and 
Goldsmith, 1982). 
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Immunoperoxidase Staining 
Light microscopy. A subconfluent mono- 
layer of IPLB-SF-21 cells was infected with 
100 PFU virus and incubated at 28” for 20 
hr. The medium was removed and the cells 
were fixed for 30 set in buffered formol- 
acetone, pH 4.5, (Volkman and Goldsmith, 
1981). Cells were incubated 30 min with 
undiluted DMEM containing AcVl, rinsed 
with 0.05 il4 Tris-buffered saline, pH 7.6, 
and, for indirect staining, incubated with 
horseradish peroxidase coupled goat anti- 
mouse IgG for an additional 30 min before 
being stained and dehydrated (Volkman 
and Goldsmith, 1981). 
Electron microscopy. IPLB-SF-21 cells 
were seeded as subconfluent monolayers in 
35-mm diameter tissue culture dishes and 
infected at a multiplicity of infection 
(m.o.i.) of 10. After a 2-hr adsorption pe- 
riod, the inoculum was removed and fresh 
medium was added. A 27-hr incubation pe- 
riod at 28” followed, then the medium was 
removed and the cells were fixed for 15 min 
with 2.5% glutaraldehyde in 0.1 ilf phos- 
phate buffer, pH 7.4. The cells were treated 
with DMEM alone or containing AcVi, and 
subsequently processed by the peroxidase 
anti-peroxidase (PAP)-staining procedure 
described elsewhere (Volkman and Gold- 
smith, 1981). Following PAP staining, the 
cells were postfixed in 1% 0~0~ (phosphate 
buffer, pH 7.0) for 1 hr, dehydrated, and 
embedded as described previously (Volk- 
man and Goldsmith, 1983). 
Isotopic Labeling 
To prepare r5S]methionine or N-acetyl- 
D-[1-3Hlglucosamine-labeled BV, near con- 
fluent cell monolayers in 75-ml cell culture 
flasks were infected (or mock infected) at 
28” with BV at an m.o.i. of 10. The inoculum 
was allowed to adsorb for 2 hr while the 
flasks were gently rocked on a Bellco rocker 
platform, then the inoculum was removed 
and 10 ml/flask of fresh medium was 
added. At 7 hr post infection (p.i.) the com- 
plete medium was removed and 10 ml 
labeling medium, either deficient in methi- 
onine (for [35S]methionine labeling) or con- 
taining 1110th normal glucose concentra- 
tion (for N-acetyl-D-[l-3H]glucosamine la- 
beling) and 2% dialyzed fetal calf serum 
were added to each flask and incubated for 
2 hr. This medium was removed and 8 ml 
labeling medium plus 25 &i/ml [35S]me- 
thionine or 40 &Wrnl N-acetyl-D-[l-3H]- 
glucosamine were added per flask. The cells 
were rocked gently until 27 hr p.i., at which 
time BV was harvested. For some exper- 
iments, 5 pg/ml tunicamycin (a glycosy- 
lation inhibitor) was added at the time of 
infection and was maintained throughout 
the starvation and labeling periods. 
Immunoprecipitution, SDS-PAGE, and 
Autoradiography 
BV was harvested by removing the me- 
dium from labeled cell cultures at 27 hr 
p.i., centrifuging at 1000 g for 10 min to 
remove any floating cells and large debris, 
and then centrifuging the supernatant fluid 
for 1 hr at 50,000 g to pellet the virus. The 
virus pellets were resuspended in 0.2 ml 
solubilization buffer (0.01 M Tris, pH 7.6, 
0.15 M NaCl, 0.001 M EDTA, 0.5% Nonidet 
P40, 0.877% P-D-octyl-glucoside, 1% apro- 
tinin, and 0.002 M phenylmethylsulfonyl- 
fluoride, and rocked for 3 hr at 4”. Solu- 
bilized virus was centrifuged at 50,000 g 
for 1 hr at 4”, and the supernatant fractions 
were treated with 25 ~1 normal rabbit 
serum plus 15-20 ng preswollen Protein A- 
Sepharose CL-4B beads, rocked for 1 hr at 
4”, and centrifuged to preclear the soluble 
antigen-containing fraction. AcVl (7.5 pg) 
was added to each sample along with 96 
pg Protein A-Sepharose CL-4B beads sat- 
urated with rabbit anti-mouse IgG. The 
samples were gently rocked overnight at 
4”. Following this, the beads were pelleted 
and washed 4 times with solubilization 
buffer, then resuspended and boiled in 
SDS-2 mercaptoethanol buffer for 10 min. 
The boiled samples were loaded onto 10 or 
12% SDS-PAGE gels (Laemmli, 1970) and 
electrophoresed at constant current (30 mA 
per gel) for approximately 4 hr. The gels 
were treated with En3Hance (New England 
Nuclear) and dried under vacuum. Labeled 
proteins were detected by autoradiography 
with Kodak X-Omat AR film and a DuPont 
lightning-plus intensifying screen. 
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RESULTS 
Absence of Reactivity with LOVAL 
Monoclonal antibody AcVl was gener- 
ated to the BV phenotype of AcNPV, and 
was found to neutralize that form of the 
virus (Hohmann and Faulkner, 1983). It 
was therefore of interest to determine 
whether it neutralized or recognized 
AcNPV LOVAL. The results of a compar- 
ative neutralization test of AcVi versus BV 
and LOVAL are presented in Fig. 1. A di- 
lution of 1500 of AcVr-containing cell cul- 
ture medium completely neutralized BV 
while no neutralization of the LOVAL form 
was achieved even with a 1:2 dilution of 
the same medium. Comparative ELISA re- 
sults, shown in Fig. 2, indicated that no 
detectable reaction between AcVi and 
LOVAL could be obtained, while AcVl 
readily recognized BV. 
Location of the AC& Target Antigen(s) 
To determine the cellular location of the 
target antigen(s) of AcVl, infected cells 
were examined by immunolight and im- 
munoelectron microscopy. Figure 3 shows 
the results of the indirect immunoperox- 
idase staining of a mixture of infected and 
uninfected IPLB-SF-21 cells fixed with 
formol-buffered acetone (to expose intra- 
-Log 
10 
Antibody Dilution 
FIG. 1. Neutralization of AcNPV BV (0) and LOVAL 
(m) with AcV,-containing DMEM. 
-Log ,. Antibody Dilution 
FIG. 2. ELISA of AcNPV BV versus AcV,-containing 
DMEM (0) or DMEM alone (0), and AcNPV LOVAL 
versus AcV,-containing DMEM (m) or DMEM 
alone (Cl). 
cellular antigens) and treated with DMEM- 
containing AcVi. The staining obtained 
was heavy on the surface of infected cells, 
recognizable by the condensed virogenic 
FIG. 3. Indirect immunoperoxidase staining of AcV,- 
treated infected (arrows) and uninfected formol-buff- 
ered acetone fixed cells. Even though internal antigens 
were exposed only surface antigens stained signifi- 
cantly. No nuclear staining is evident. 
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stroma in the nuclei (Volkman and Sum- 
mers, 1975). Staining occurred most heavily 
on cell surfaces not in contact with other 
cells. There was a notable lack of staining 
in the nuclei of infected cells. 
Figures 4,5, and 6 show electron micro- 
graphs of infected and uninfected cells ex- 
posed to DMEM with or without AcVl. Cell 
surface staining was evident in infected 
cells, although staining intensity varied 
from regions where it was undetectable to 
areas of very heavy staining (Fig. 4C). 
Electronmicrographs of higher magnifi- 
cation revealed that relatively heavy 
staining was correlated with regions of 
concentrated virus budding (Fig. 5C). 
Higher concentrations of AcVl also re- 
sulted in the heavy staining of regions of 
virus budding (Fig. 5D). Staining in areas 
of relatively low budding activity with the 
appropriate dilution of antibody revealed 
that the target antigen was a component 
of the plasma membrane before any as- 
sociation with viral nucleocapsid was ap- 
parent (Fig. 6). As nucleocapsids ap- 
proached the plasma membrane, however, 
the antigen appeared to become concen- 
trated at the site of initial contact, the lo- 
cation where peplomers form (Figs. 6A, B, 
D) (Adams et aL, 1977). Although staining 
was more intense at the peplomer end of 
the BV envelope, it could be detected all 
around the virion envelope (Fig. 6C). 
Immunoprecip*tation of BV Structural 
Proteins with AcV, 
To determine the molecular weight of 
the target antigen of AcVr , AcNPV BV was 
radioactively labeled with 35[S]methionine 
or N-acetyl-D-[l-3H]glucosamine, solubi- 
lized with nonionic detergents, immuno- 
FIGS. 4 (left), 5 (right). Immunoelectron micrographs of portions of PAP-stained uninfected (A) 
and infected (B, C, D) cells treated with either undiluted DMEM alone (B), or DMEM containing 
AcV,, diluted 1:50 (C), 1:5 (D), or not diluted (A). The bar represents 1 pm in Fig. 4 and 100 nm 
in Fig. 5. 
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FIG. 6. Immunoelectron micrographs of portions of 
PAP-stained cells with budding and budded AcNPV 
evident. All cells were treated with a 150 dilution of 
AcV,-containing DMEM. The bar represents 100 nm. 
Arrows indicate the stained peplomers. 
precipitated, and analyzed by SDS-PAGE 
and autoradiography. Four proteins of dif- 
ferent molecular weights were consistently 
precipitated in several experiments, with 
the most heavily labeled one being ap- 
proximately 64,000, one of intermediate 
intensity at approximately 49,000, and two 
minor bands at 127,000 and 59,000 (Fig. 7). 
All four were labeled with both radioactive 
methionine and acetyl-glucosamine (Figs. 
7A, C). Minor bands of molecular weights 
less than 49,000 were also obtained, but the 
molecular weights and the intensity of the 
bands were variable from experiment to 
experiment. Treatment of cells with 5 pg/ 
ml tunicamycin, an inhibitor of N-aspar- 
agine-linked glycosylation (Klenk and Rott, 
1980), resulted in the precipitation of no 
acetyl-glucosamine-labeled proteins (Fig. 
7D), and only a 59,000-molecular weight 
methionine-labeled protein (Fig. 7B). Pel- 
leted BV from tunicamycin-treated in- 
fected cultures was negatively stained and 
viewed by electron microscopy to confirm 
its presence in those preparations (not 
shown). Processing of control samples from 
labeled uninfected cells with and without 
tunicamycin resulted in the precipitation 
of no labeled proteins (not shown). 
DISCUSSION 
The presence of glycoproteins on the 
surface is a common property of enveloped 
animal viruses (Choppin and Sheid, 1980). 
In most enveloped viruses, the glycopro- 
teins are present in the form of peplomers 
and are functional in the early interactions 
of the virus and host cell; either in the 
initial adsorption and attachment to the 
cell, and/or in the subsequent penetration 
of the cell (Choppin and Sheid, 1980; Klenk 
and Rott, 1980). Adsorption of a given virus 
often requires interaction with a specific 
receptor, thus peplomers potentially play 
an important role in the specificity of in- 
fection. Enveloped virus peplomers are 
usually composed of several glycoprotein 
molecules, either the same molecular spe- 
127-, 
64+ 
% 
FIG. 7. Autoradiogram of BV peptides immuno- 
precipitated with AcVi. BV was labeled with either 
[%]methionine (A, B) or N-acetyl-D-[1-‘Hjglucos- 
amine (C, D) in the presence (B, D) or absence (A, 
C) of tunicamycin. Molecular weights (in thousands) 
are indicated. 
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ties or different fragments that arise by 
proteolytic cleavage of a common precur- 
sor. Some viruses have only one type of 
peplomer, while others possess two types, 
each formed by different glycoprotein spe- 
cies (Klenk and Rott, 1980). Commonly it 
is the viral glycoprotein that is the target 
of neutralizing antibodies. 
Immunoprecipitation of radiolabeled BV 
structural proteins with the neutralizing 
monoclonal antibody AcVr yielded four 
bands of different molecular weights when 
analyzed under reducing conditions by 
SDS-PAGE and autoradiography. The fact 
that the same banding pattern was ob- 
tained when the precipitated BV proteins 
were labeled with N-acetyl-D-[l-3H]glu- 
cosamine as with r5S]methionine indicated 
all the proteins involved were glycopro- 
teins. The addition of tunicamycin, as ex- 
pected, blocked the glycosylation of the 
proteins in question. These results in- 
dicated that the oligosaccharides were 
N-linked rather than O-linked. Although 
recently O-linkages have been reported in 
some viral glycoproteins (Stern and Sefton, 
1982; Zezulak and Spear, 1983), the ma- 
jority reported so far have been N linkages 
(Klenk and Rott, 1980). When tunicamycin 
was used in conjunction with the methi- 
onine label, a protein of molecular weight 
59,000 was immunoprecipitated. Whether 
or not BVP 59 is a slightly glycosylated 
version of this same protein remains to be 
determined. 
Stiles et al. (1983) reported that treat- 
ment of AcNPV-infected TN-368 cells with 
5 pg/ml tunicamycin resulted in a 99% re- 
duction in BV titer, while it had no effect 
on the infectivity of OV. These results are 
consistent with our observations that this 
tunicamycin-sensitive glycoprotein is crit- 
ical to the infectivity of BV, but is not a 
component of LOVAL. 
Several ideas can be put forth as possible 
explanations of why four bands were ob- 
tained in the immunoprecipitation exper- 
iments: (1) the four proteins were precip- 
itated individually because they share an 
epitope reactive with AcVl due to a pre- 
cursor-product relationship of some kind; 
(2) the precipitated proteins are not related 
but merely share epitopes cross-reactive 
with AcV,; (3) not all the precipitated pro- 
teins interact directly with AcVi but are 
precipitated because of noncovalent link- 
ages (such as ionic and hydrogen bonding), 
or covalent disulfide bonding with a protein 
(peptide) that does react with AcVr and 
are subsequently separated by the dena- 
turing and reducing conditions of the Lae- 
mmli gel system; (4) the epitope reactive 
with AcVl is formed by the association of 
two or more of the precipitated proteins; 
(5) the 127,000 band represents dimers of 
the 64,000 protein and the other minor 
bands are the result of sample preparatory 
procedures and/or proteolytic activity 
during sample preparation; (6) combina- 
tions of the above. Certainly, further ex- 
perimentation is required to determine 
which (if any) of the above listed expla- 
nations most closely approximates the sit- 
uation, but the hypothesis that the BV ep- 
itope in question is dependent upon the 
association of at least two proteins (or 
peptide chains) is consistent with infor- 
mation collected over several years of ex- 
perimentation. BVP 64 is one of the major 
proteins of AcNPV BV (Smith and Sum- 
mers, 1978) and though LOVAL contains 
a structural protein of the same molecular 
weight, the BV protein is considerably 
more abundant. BVP 64 is the major struc- 
tural protein precipitated by AcVl, but an- 
tiserum made to electrophoretically pu- 
rified BVP 64 does not neutralize BV (not 
shown). Further, antiserum made to 
AcNPV LOVAL will react with BVP 64, 
(Volkman, 1983) but will not neutralize BV 
(Volkman et al, 1976). Additionally, AcVl 
reactivity with BV (as demonstrated by 
ELISA) is destroyed if the BV antigen is 
first boiled with the standard Laemmli 
SDS-PAGE sample buffer as is customary 
before gel analysis (unpublished results). 
The loss of reactivity by this treatment 
explains the lack of activity obtained by 
Hohmann and Faulkner (1983) in their 
Western blot anaylsis of BV with AcVl. 
Immunoperoxidase staining in conjunc- 
tion with both light and electron micros- 
copy revealed that cell-associated AcVl 
target antigen(s) were located at the sur- 
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face of cells in the prepolyhedra stage of 
infection (Volkman and Summers, 1975), 
and appeared to be preferentially substi- 
tuted into the plasma membrane where no 
contact with another cell occurred. Fur- 
ther, immunoelectron microscopy revealed 
that the target antigen(s) were substituted 
into the plasma membrane in advance of 
virus budding, but were concentrated at 
the point of nucleocapsid attachment, re- 
sulting in differential staining of the en- 
velope of the budded virus. The introduc- 
tion of the viral glycoprotein into the 
plasma membrane before viral budding is 
the normal process observed with other 
enveloped viruses (Klenk and Rott, 1980). 
Staining results indicated that the AcVl 
target antigen(s) were present in the viral 
envelope all around the virion, but were 
more highly concentrated at the end with 
peplomers. Adams et ah (1977), after hav- 
ing reviewed numerous electron micro- 
graphs of in vivo and in vitro budding bac- 
uloviruses, described the plasma mem- 
branes of infected cells as having a “spiny 
coat” appearance (to various degrees) in 
areas where no peplomers were seen. Since 
most enveloped-virus glycoproteins are 
present at the surface in the form of spikes 
(Klenk and Rott, 1980), it is speculated that 
these antigens may be components of the 
spines and peplomers observed in the BV 
envelope (Adams et al., 1977). Whether or 
not this is true, and whether the same pro- 
teins are components of both the spines 
and peplomers remains to be determined. 
Reciprocal neutralization and adsorption 
experiments (Volkman et aa, 1976) have 
indicated that LOVAL and BV are neu- 
tralized by different populations of anti- 
bodies, so it is not surprising that a mono- 
clonal antibody that neutralized BV would 
not neutralize LOVAL. Since antiserum to 
LOVAL does not neutralize BV (Volkman 
et al., 1976), it also was not surprising that 
the target epitope of the neutralizing an- 
tibody AcV, was absent altogether from 
LOVAL, as indicated by both ELISA and 
the absence of immunoperoxidase staining 
of infected cell nuclei in acetone-fixed cells. 
It may be that this difference in glycopro- 
teins is responsible for the difference in 
infectivity and specificity of the two phe- 
notypes. 
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